Literature DB >> 30426552

Gene therapy by lentivirus-mediated RNA interference targeting extracellular-regulated kinase alleviates neuropathic pain in vivo.

Lei Jia1, Yang Zhang1, Yu-Juan Qu1, Juan Huai1, Hui Wei1, Shou-Wei Yue1.   

Abstract

BACKGROUNDS: Neuropathic pain is an abnormal pain, which is related to the activation of extracellular-regulated kinase (ERK) signaling. This study was to investigate the effects of ERK knockdown via lentivirus-mediated RNA interference on allodynia in rats with chronic compression of the dorsal root ganglia (DRG) and to uncover the potential mechanisms.
METHODS: The model of chronic compression of the dorsal root ganglia (CCD) was established in rats by surgery. Gene silence was induced by injecting rats with lentivirus expressing ERK short hairpin RNA (shRNA). Behavioral test was performed by calculating paw withdrawal mechanical threshold (PWMT) and thermal paw withdrawal latency (TPWL).
RESULTS: We firstly generated lentivirus expressing ERK shRNA to downregulate ERK gene expression both in vitro and in vivo by using Western blot analysis and quantitative reverse transcription polymerase chain reaction. In CCD, ERK mRNA, and protein levels in DRG neurons were dramatically increased, accompanied with decreased PWMT and TPWL. Lentivirus-mediated RNA interference decreased ERK gene expression in DRG neurons and normalized the PWMT and TPWL in CCD rats, but not in rats infected with lentivirus expressing negative control shRNA. Further, calcium responses of DRG neurons to the hypotonic solution and 4α-phorbol 12,13-didecanoate were enhanced in CCD rats, which were suppressed by lentivirus-mediated ERK gene silence. Finally, the levels of transient receptor potential vanilloid 4 gene expressions in DRG neurons and L4 to L5 spinal cord isolated from CCD rats were dramatically upregulated, which were reversed by lentivirus-mediated ERK gene knockdown.
CONCLUSION: Lentivirus-mediated RNA interference (RNAi) silencing targeting ERK might reverse CCD-induced neuropathic pain in rats through transient receptor potential vanilloid 4.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA interference; extracellular-regulated kinase; gene therapy; neuropathic pain; transient receptor potential vanilloid 4

Year:  2018        PMID: 30426552     DOI: 10.1002/jcb.28090

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  3 in total

1.  Upregulation of TLR9 may contribute to activation of microglia and painful diabetic neuropathy via the p38 MAPK pathway in rats.

Authors:  Zhaoxia Niu; Lei Bao; Jing Chen
Journal:  Histol Histopathol       Date:  2021-12-10       Impact factor: 2.303

2.  Identification of Differentially Expressed Genes and Key Pathways in the Dorsal Root Ganglion After Chronic Compression.

Authors:  Zhanhui Du; Sen Yin; Xiuhui Song; Lechi Zhang; Shouwei Yue; Xiaofeng Jia; Yang Zhang
Journal:  Front Mol Neurosci       Date:  2020-05-05       Impact factor: 5.639

3.  DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84.

Authors:  Wen-Shuang Gao; Yu-Juan Qu; Juan Huai; Hui Wei; Yang Zhang; Shou-Wei Yue
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.